title: [Juvenile Still's disease: a case report of treatment with infliximab].
authors.affiliation: Service de Rhumatologie, Hôpital la Rabta, Tunis, Tunisie. nihelmed@lycos.fr
authors.forename: N
authors.initials: N
authors.lastname: Meddeb
authors.forename: N
authors.initials: N
authors.lastname: Rammeh
authors.forename: N
authors.initials: N
authors.lastname: Gandoura
authors.forename: M
authors.initials: M
authors.lastname: Elleuch
authors.forename: E
authors.initials: E
authors.lastname: Cheour
authors.forename: H
authors.initials: H
authors.lastname: Sahli
authors.forename: S
authors.initials: S
authors.lastname: Hamza
authors.forename: A
authors.initials: A
authors.lastname: Maalej
authors.forename: S
authors.initials: S
authors.lastname: Sellami
mesh_terms: D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D000069285:Infliximab; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D013256:Steroids
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D013256:Steroids; D000069285:Infliximab; D008727:Methotrexate